Vitamin K antagonist rodenticides display different teratogenic activity - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Reproductive Toxicology Année : 2020

Vitamin K antagonist rodenticides display different teratogenic activity

(1) , (1) , (1) , (1)
1

Résumé

Vitamin K antagonists (VKA) are not recommended during pregnancy because warfarin (a first-generation VKA) is associated with a malformation syndrome "the fetal warfarin syndrome" (FWS). VKA are also used for rodent management worldwide. Recently, the Committee for Risk Assessment responsible for the European chemical legislation for advances on the safe use of chemicals had classed 8 anticoagulant used as rodenticides in the reprotoxic category 1A or 1B. This classification emerges from a read-across prediction of toxicity considering the warfarin malformation syndrome. Herein, our study explores the teratogenicity of warfarin at the human therapeutic dose and that of bromadiolone, a second-generation anticoagulant rodenticide. Using a rat model, our study demonstrates that warfarin used at the therapeutic dose is able to induce teratogenicity, while in the same conditions bromadiolone does not induce any teratogenic effect, challenging the classification of all VKA as reprotoxic molecules.
Fichier non déposé

Dates et versions

hal-02501177 , version 1 (06-03-2020)

Identifiants

Citer

Thomas Chetot, Shira Taufana, Etienne Benoit, Virginie Lattard. Vitamin K antagonist rodenticides display different teratogenic activity. Reproductive Toxicology, 2020, 93, pp.131-136. ⟨10.1016/j.reprotox.2020.02.003⟩. ⟨hal-02501177⟩
48 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More